SCOTUS ‘shouldn’t eliminate assignor estoppel altogether’

Patrick Wingrove

March 05, 2021

With the deadline for amicus briefs now passed, counsel set out why the US Supreme Court should or shouldn’t preserve assignor estoppel in Minerva v Hologic

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Patrick Wingrove

Deputy managing editor Managing IP

Patrick assists with editorial agenda management, and regularly reports on patent-related issues, including FRAND, supplementary protection certificates and patent eligibility, as well as trade secrets. He also chairs industry events and produces conference newspapers.

More from across our site

Patents

PONTYPRIDD, MID GLAMORGAN, WALES, UK - SEPTEMBER 25, 2024: THATCHERS CIDER ALCHOHOLIC DRINKS ON DISPLAY

This week on MIP: UK proposes AI opt-out | Cider trademark row

A UK government consultation on AI and copyright, a patent blow for Lenovo and a trademark row over cider were among the big talking points this week

Max Walters, December 20, 2024

Patents

Editor’s picks: top Managing IP stories of 2024

Our most popular stories of the year included a rundown of the 50 most influential people in IP, our in-house ones to watch, and UPC news

Max Walters, December 20, 2024

Awards

LMG Life Sciences Awards EMEA 2025: open for entries

It is time to submit nominations for the sixth annual Life Sciences Awards EMEA

James Wilson, December 19, 2024

Trade Secrets

Bigger and better: why former Yulchon partner returned home

Keejeong Kim, who returned to Yulchon after a four-year gap, said he was intrigued by the opportunity to work on neighbouring areas of law to IP

Sukanya Sarkar, December 19, 2024

Patents

Lumenci eyes accelerated growth with private equity investment

The IP consulting firm hopes to expand its services and outreach with the support of investors VSS Capital Partners and Century Equity Partners

Sukanya Sarkar, December 19, 2024

Patents

Dexcom headquarters building exterior. DexCom, Inc. develops, manufactures, and distributes glucose monitoring systems for diabetes management. - San Diego, California, USA - 2020

UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions

This update includes a ruling from the Court of Appeal, a judgment of the Paris Local Division, news of upcoming hearings, and predictions for 2025

James Nurton, December 19, 2024

2024 review: counsel plagued by AI uncertainty and copyright questions

US counsel review the key copyright and trademark trends of 2024, including generative AI disputes and SCOTUS cases

Rani Mehta, December 18, 2024

Patents

Silhouette of business man following his ambitions, Generative Ai illustration

Weekly take: Consolidation and IP transactions in firms’ 2025 sights

If 2024 is anything to go by, the next 12 months could see more IP firms seek investment opportunities while IP lawyers are increasingly likely to work alongside other functions

Max Walters, December 18, 2024

Patents

2024 review: US counsel reflect on top patent trends

Practitioners reflect on the impact of USPTO guidance, as well as PTAB and litigation trends

Rani Mehta, December 18, 2024

Patents

The IP Lounge: Top 50 people in IP | social media habits

We discuss Managing IP’s 50 most influential people in IP list and look back on the biggest talking points in the last month

Max Walters, December 16, 2024